NCT01471964 · Interventional trial
Study to Assess Safety and Tolerability of MLN8237, In Combination With Erlotinib to Treat Non-Small Cell Lung Cancer
Overall registry status Terminated
Phase 1 · Phase 2
Conditions Non-small Cell Lung Cancer Metastatic, Non-small Cell Lung Cancer Recurrent
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory